International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Depression as a Risk Factor for Relapse After Inpatient Opioid Detoxification: 1-Year Follow-Up Study

Harsh Chalana 1 , * , Tanu Kundal 1 and Amandeep Singh Malhari 1
Authors Information
1 Department of Psychiatry, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India
Article information
  • International Journal of High Risk Behaviors and Addiction: September 2017, 6 (3); e59543
  • Published Online: August 19, 2017
  • Article Type: Research Article
  • Received: August 23, 2016
  • Revised: October 7, 2016
  • Accepted: December 24, 2016
  • DOI: 10.5812/ijhrba.59543

To Cite: Chalana H, Kundal T, Singh Malhari A. Depression as a Risk Factor for Relapse After Inpatient Opioid Detoxification: 1-Year Follow-Up Study, Int J High Risk Behav Addict. 2017 ; 6(3):e59543. doi: 10.5812/ijhrba.59543.

Copyright © 2017, International Journal of High Risk Behaviors and Addiction. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Strain EC, Lofwall MR, Jaffe JH. Kaplan & Sadock's Comprehensive textbook of psychiatry. 2000; : 1360-87
  • 2. Chalana H, Sachdeva JK, Kundal T, Malhari AS, Choudhary R. A Double - Blind, Placebo - Controlled, Randomized Study Comparing Quetiapine with Placebo, Along with Oral Naltrexone, in the Treatment of Opioid Dependent Patients. J Evol Med Dent Sci. 2015; 4(53): 9158-67[DOI]
  • 3. Koob GF, Maldonado R, Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci. 1992; 15(5): 186-91[DOI]
  • 4. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997; 278(5335): 52-8[PubMed]
  • 5. Feltenstein MW, See RE. The neurocircuitry of addiction: an overview. Br J Pharmacol. 2008; 154(2): 261-74[DOI][PubMed]
  • 6. Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005; 3(1): 13-21[PubMed]
  • 7. Goldsmith RJ, Ries RK. Principles of Addiction Medicine. 2003; : 1263-76
  • 8. Collins RL, Parks GA, Marlatt GA. Social determinants of alcohol consumption: the effects of social interaction and model status on the self-administration of alcohol. J Consult Clin Psychol. 1985; 53(2): 189-200[PubMed]
  • 9. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002; 59(4): 375-80[PubMed]
  • 10.
  • 11. Balhara YP, Ranjan R, Dhawan A, Yadav D. Experiences from a community based substance use treatment centre in an urban resettlement colony in India. J Addict. 2014; 2014: 982028[DOI][PubMed]
  • 12. Smyth BP, Barry J, Keenan E, Ducray K. Lapse and relapse following inpatient treatment of opiate dependence. Ir Med J. 2010; 103(6): 176-9[PubMed]
  • 13. Hakansson A, Hallen E. Predictors of dropout from inpatient opioid detoxification with buprenorphine: a chart review. J Addict. 2014; 2014: 965267[DOI][PubMed]
  • 14. Majumder P, Sarkar S, Gupta R, Patra BN, Balhara YP. Predictors of retention in treatment in a tertiary care de-addiction center. Indian J Psychiatry. 2016; 58(1): 27-30[DOI][PubMed]
  • 15. Childress AR, Ehrman R, McLellan AT, MacRae J, Natale M, O'Brien CP. Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat. 1994; 11(1): 17-23[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments